Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 May 1;109(5):1315-1316.
doi: 10.3324/haematol.2023.284148.

Unveiling amphiregulin: a blood-based biomarker for graft- versus-host disease risk assessment and monitoring

Sung Won Choi  1
Affiliations
Editorial

Unveiling amphiregulin: a blood-based biomarker for graft- versus-host disease risk assessment and monitoring

Sung Won Choi. Haematologica. .
No abstract available

PubMed Disclaimer

References

    1. Paczesny S, Levine JE, Braun TM, Ferrara JL. Plasma biomarkers in graft-versus-host disease: a new era? Biol Blood Marrow Transplant. 2009;15(1 Suppl):33-38. - PMC - PubMed
    1. Paczesny S, Krijanovski OI, Braun TM, et al. A biomarker panel for acute graft-versus-host disease. Blood. 2009;113(2):273-278. - PMC - PubMed
    1. Ferrara JL, Harris AC, Greenson JK, et al. Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease. Blood. 2011;118(25):6702-6708. - PMC - PubMed
    1. Vander Lugt MT, Braun TM, Hanash S, et al. ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. N Engl J Med. 2013;369(6):529-539. - PMC - PubMed
    1. Holtan SG, Khera N, Levine JE, et al. Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors. Blood. 2016;128(19):2350-2358. - PMC - PubMed

Publication types

MeSH terms